Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Show more
REDWOOD CITY, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on September 3, 2024, the Compensation Committee of Adverum’s Board of...
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
- 6E10 dose of Ixo-vec selected for Phase 3 pivotal trials - LUNA 26-week interim analysis presented at ASRS 2024 demonstrating a potential best-in-class product profile of Ixo-vec, with similar...
REDWOOD CITY, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.35 | 4.96453900709 | 7.05 | 7.67 | 6.93 | 186576 | 7.12568067 | CS |
4 | 0.19 | 2.63522884882 | 7.21 | 7.67 | 6.54 | 145909 | 7.05848413 | CS |
12 | 0.46 | 6.62824207493 | 6.94 | 10.14 | 6.39 | 285519 | 7.71174013 | CS |
26 | -7.6 | -50.6666666667 | 15 | 18 | 6.38 | 340349 | 9.93345937 | CS |
52 | -7.9 | -51.6339869281 | 15.3 | 29.8 | 6.38 | 747830 | 15.71232048 | CS |
156 | -15.2 | -67.2566371681 | 22.6 | 29.8 | 5.31 | 844903 | 15.17273652 | CS |
260 | -54.3 | -88.0064829822 | 61.7 | 269.8 | 5.31 | 1102719 | 56.76312727 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.